US Patent Issued to Genentech on Feb. 10 for "Methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosis using an inhibitor of Bruton's tyrosine kinase" (California Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,372, issued on Feb. 10, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosis using an inhibitor of Bruton's tyrosine kinase" was invented by Tamiko Katsumoto (Millbrae, Calif.), Leslie Chinn (South San Francisco, Calif.), Alyssa Mariko Morimoto (San Mateo, Calif.) and David James Haddon (Millbrae, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosus using fenebrutinib, an inhibitor of Bruton's tyr...